XML 116 R106.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Mezzanine and Stockholders Equity- Schedule of Preferred and Temporary Equity (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Jun. 05, 2024
Jun. 04, 2024
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Nov. 23, 1993
Amount Outstanding (in millions)                
Preferred stock $ 503,000,000 $ 503,000,000     $ 503,000,000      
Common stock [1] $ 4,000,000 $ 4,000,000     $ 2,000,000      
Shares Authorized                
Common stock (in shares) 666,666,666 666,666,666 666,666,666 300,000,000 300,000,000      
Shares Issued                
Common stock (in shares) 358,864,464 358,864,464     248,051,930      
Shares Outstanding                
Common stock outstanding (in shares) 351,304,364 351,304,364     240,688,790      
Par Value                
Preferred stock (in usd per share) $ 0.01 $ 0.01     $ 0.01      
Noncumulative convertible preferred stock (in usd per share) 0.01 0.01     0.01 $ 0.01 $ 0.01  
Common stock (in usd per share) $ 0.01 $ 0.01     $ 0.01     $ 0.01
Preferred Stock (Par Value: $0.01)                
Temporary Equity [Line Items]                
Dividend rate percentage   6.375%            
Noncumulative Series A Preferred Stock                
Amount Outstanding (in millions)                
Preferred stock $ 503,000,000 $ 503,000,000            
Shares Authorized                
Preferred stock (in shares) 5,000,000 5,000,000            
Shares Issued                
Preferred stock (in shares) 515,000 515,000            
Shares Outstanding                
Preferred stock (in shares) 515,000 515,000            
Par Value                
Preferred stock (in usd per share) $ 0.01 $ 0.01            
Liquidation Preference                
Preferred Stock $ 1,000 $ 1,000            
Noncumulative Series B Preferred Stock                
Temporary Equity [Line Items]                
Dividend rate percentage   13.00%            
Amount Outstanding (in millions)                
Noncumulative convertible preferred stock $ 258,000,000 $ 258,000,000            
Shares Authorized                
Noncumulative convertible preferred stock (in shares) 267,062 267,062            
Shares Issued                
Noncumulative convertible preferred stock (in shares) 192,062 192,062            
Shares Outstanding                
Noncumulative convertible preferred stock (in shares) 192,062 192,062            
Par Value                
Noncumulative convertible preferred stock (in usd per share) $ 0.01 $ 0.01            
Liquidation Preference                
Noncumulative convertible preferred stock $ 0 $ 0            
Noncumulative Convertible Preferred Stock Series C                
Amount Outstanding (in millions)                
Noncumulative convertible preferred stock $ 337,000,000            
Shares Authorized                
Noncumulative convertible preferred stock (in shares) 523,369 523,369            
Shares Issued                
Noncumulative convertible preferred stock (in shares) 256,307 256,307            
Shares Outstanding                
Noncumulative convertible preferred stock (in shares) 0 0            
Par Value                
Noncumulative convertible preferred stock (in usd per share) $ 0.01 $ 0.01            
Liquidation Preference                
Noncumulative convertible preferred stock $ 2,000 $ 2,000            
Non-Voting Common Equivalent Series D                
Amount Outstanding (in millions)                
Common stock $ 0 $ 0            
Shares Authorized                
Common stock (in shares) 315,000 315,000            
Shares Issued                
Common stock (in shares) 0 0            
Shares Outstanding                
Common stock outstanding (in shares) 0 0            
Par Value                
Common stock (in usd per share) $ 0.01 $ 0.01            
Liquidation Preference                
Common Stock $ 0.0001 $ 0.0001            
[1] On June 27, 2024, the Company announced a 1 for 3 reverse stock split, effective July 11, 2024. This reverse stock split is reflected retroactively in all periods presented. See Note 19 - Subsequent Events